IL157461A0 - Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer - Google Patents

Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer

Info

Publication number
IL157461A0
IL157461A0 IL15746102A IL15746102A IL157461A0 IL 157461 A0 IL157461 A0 IL 157461A0 IL 15746102 A IL15746102 A IL 15746102A IL 15746102 A IL15746102 A IL 15746102A IL 157461 A0 IL157461 A0 IL 157461A0
Authority
IL
Israel
Prior art keywords
deivatives
carboxamido
imidazo
medicaments
pyridine
Prior art date
Application number
IL15746102A
Other languages
English (en)
Original Assignee
Astrazeneca Ab Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0100798A external-priority patent/SE0100798D0/xx
Priority claimed from SE0103291A external-priority patent/SE0103291D0/xx
Application filed by Astrazeneca Ab Astrazeneca Ab filed Critical Astrazeneca Ab Astrazeneca Ab
Publication of IL157461A0 publication Critical patent/IL157461A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15746102A 2001-03-08 2002-03-05 Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer IL157461A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0100798A SE0100798D0 (sv) 2001-03-08 2001-03-08 New use
SE0103291A SE0103291D0 (sv) 2001-10-03 2001-10-03 New use
PCT/SE2002/000375 WO2002069968A1 (en) 2001-03-08 2002-03-05 New use

Publications (1)

Publication Number Publication Date
IL157461A0 true IL157461A0 (en) 2004-03-28

Family

ID=26655407

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15746102A IL157461A0 (en) 2001-03-08 2002-03-05 Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer

Country Status (15)

Country Link
US (2) US20040082605A1 (cs)
EP (1) EP1370261A2 (cs)
JP (1) JP2004520422A (cs)
KR (1) KR100904599B1 (cs)
CN (1) CN1496259A (cs)
BG (1) BG108144A (cs)
BR (1) BR0207762A (cs)
CA (1) CA2440100A1 (cs)
CZ (1) CZ20032398A3 (cs)
EE (1) EE05234B1 (cs)
IL (1) IL157461A0 (cs)
MX (1) MXPA03007888A (cs)
NO (1) NO20033919L (cs)
SK (1) SK10982003A3 (cs)
WO (1) WO2002069968A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
WO2004012659A2 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
KR20050052500A (ko) * 2002-09-19 2005-06-02 쉐링 코포레이션 사이클린 의존성 키나제 억제제로서의 이미다조피리딘
CA2499593C (en) * 2002-09-19 2011-08-16 Michael P. Dwyer Pyrazolopyridines as cyclin dependent kinase inhibitors
PL377581A1 (pl) * 2003-02-17 2006-02-06 Altana Pharma Ag Połączenia zawierające imidazopirydyny oraz ich zastosowanie do leczenia chorób zapalnych przewodu pokarmowego
JPWO2011102460A1 (ja) * 2010-02-19 2013-06-17 学校法人関西医科大学 胃潰瘍の予防又は治療剤、経口投与薬、及び胃潰瘍の予防又は治療剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT290523B (de) * 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3922387A1 (de) * 1989-07-07 1991-01-17 Kali Chemie Pharma Gmbh N-benzyl-n-((1s,5s)-6,6-dimethylbicyclo/3.1.1/hept-2-ylaethoxy-aethyl)-morpholinium-salze enthaltende gastroprotektiv wirksame pharmazeutische zubereitungen
NZ235877A (en) * 1989-11-02 1992-09-25 Mcneil Ppc Inc Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
KR920002148A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
DK0550083T3 (da) * 1991-12-06 1999-10-11 Glaxo Group Ltd Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
WO1998042707A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
EP1115725B1 (en) * 1998-09-23 2003-01-29 ALTANA Pharma AG Tetrahydropyridoethers
CA2370231A1 (en) * 1999-04-17 2000-10-26 Byk Gulden Lomberg Chemische Fabrik Gmbh Haloalkoxy imidazonaphthyridines

Also Published As

Publication number Publication date
US20040082605A1 (en) 2004-04-29
WO2002069968A8 (en) 2003-04-17
EE05234B1 (et) 2009-12-15
NO20033919D0 (no) 2003-09-04
EP1370261A2 (en) 2003-12-17
CA2440100A1 (en) 2002-09-12
KR20040007461A (ko) 2004-01-24
KR100904599B1 (ko) 2009-06-25
US20090170854A1 (en) 2009-07-02
SK10982003A3 (sk) 2004-02-03
MXPA03007888A (es) 2003-12-04
CN1496259A (zh) 2004-05-12
JP2004520422A (ja) 2004-07-08
CZ20032398A3 (cs) 2004-02-18
BG108144A (en) 2004-09-30
WO2002069968A1 (en) 2002-09-12
EE200300434A (et) 2003-12-15
BR0207762A (pt) 2004-06-01
NO20033919L (no) 2003-09-04

Similar Documents

Publication Publication Date Title
AU7922900A (en) Thiazole and imidazo (4,5-b) pyridine compounds and their pharmaceutical use
IL191960A (en) History of imidazo [5,1– a] pyridine and pharmaceutical preparations containing them
HUP0102556A3 (en) Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
IL160707A0 (en) 1, 8-naphthyridine derivatives as antidiabetics
HUP0104200A3 (en) 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
AU2002251546A1 (en) Pyrazolo[1,5-A]pyridines and medicines containing the same
AU2001262723A1 (en) 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
HUP0003265A3 (en) Nutritional composition for the treatment of pressure ulcers
IL147923A0 (en) 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
IL147925A0 (en) 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
HUP0102585A3 (en) Thienylazolylalcoxyethanamin derivatives preparation the same and their use as medicaments
PL349364A1 (en) Use of pyridazino[4,5-b
PL349341A1 (en) Imidazo[4,5-c]-pyridine-4-on-derivatives
NZ288609A (en) Substituted (4-thiopyridinyl) methylthio-benzimidazole (or 1h-imidazo-[2,3-b]-pyridine) and medicaments
PL366858A1 (en) Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
AU2002243363A1 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
ZA983376B (en) Process for the preparation of flupirtine maleate.
AU2001279958A1 (en) Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatorydisorders
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
IL157461A0 (en) Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer
MXPA03008894A (es) Uso de compuestos de imidazo[1,2-a]-piridin-3-il-amidas e imidazo [1,2-a]-piridin-3-il-aminas sustituidas como medicamentos.
HUP0401577A3 (en) Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
HUP0102409A3 (en) Pyrimidin-aminomethhyl-pyridine derivatives, their preparation and their use in the control of helicobacter bacteria
AU1940800A (en) Combination therapy for the treatment of sepsis